Skip to main content
Edwards Lifesciences Logo

The TRISCEND II trial for tricuspid regurgitation

Patient information



  1. Tricuspid valve regurgitation. Mayo Clinic. Accessed January 9, 2021.
  2. Edwards TRISCEND II pivotal clinical trial protocol (TRISCEND II). identifier: NCT04482062. Updated January 13, 2021. Accessed January 1, 2021.
  3. Clinical trials: what patients need to know. US Food and Drug Administration. Updated January 4, 2018. Accessed August 24, 2020. clinical-trials-what-patients-need-know.
  4. Inside Clinical Trials: Testing Medical Products in People. US Food and Drug Administration. Updated November 6, 2014. Accessed August 25, 2020. information-consumers/inside-clinical-trials-testing-medical-products-people.
  5. Edwards EVOQUE Tricuspid Valve Replacement System: Instructions for Use. Edwards Lifesciences.

Important safety information

CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use. This device is not available for marketing or commercial sale in the United States.

Edwards Lifesciences is the sponsor of the TRISCEND II trial.

Edwards, Edwards Lifesciences, the stylized E logo, EVOQUE, and TRISCEND are trademarks of Edwards Lifesciences Corporation or its affiliates. All other trademarks are the property of their respective owners

PP--US-5808 v1.0